Insulin‐sensitive hepatic Fasn expression is closely associated with the development of lipidosis leading to steatosis (Dorn et al., 2010); the reduction in hepatic Fasn expression by all three treatments paralleled the reduction in circulating insulin and hepatic lipidosis. Here, INS is linked to fatty liver disease.